About Unity Biotechnology
Unity Biotechnology is a company based in San Francisco (United States) founded in 2016.. Unity Biotechnology has raised $206 million across 5 funding rounds from investors including Fidelity Investments, WuXi AppTec and Hercules Capital. The company has 16 employees as of December 31, 2024. Unity Biotechnology offers products and services including UBX1325. Unity Biotechnology operates in a competitive market with competitors including Spark Therapeutics, Denali Therapeutics, Poseida Therapeutics, Juno Therapeutics and AskBio, among others.
- Headquarter San Francisco, United States
- Employees 16 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Unity Biotechnology, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-25.99 M34.8as on Dec 31, 2024
-
EBITDA
$-27.86 M28.52as on Dec 31, 2024
-
Total Equity Funding
$206 M (USD)
in 5 rounds
-
Latest Funding Round
$80 M (USD), Debt – Conventional
Aug 04, 2020
-
Investors
Fidelity Investments
& 17 more
-
Employee Count
16
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Unity Biotechnology
Unity Biotechnology is a publicly listed company on the OTC with ticker symbol UNBX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Unity Biotechnology
Unity Biotechnology offers a comprehensive portfolio of products and services, including UBX1325. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for treating retinal diseases by targeting cellular senescence.
Unlock access to complete
Unlock access to complete
Funding Insights of Unity Biotechnology
Unity Biotechnology has successfully raised a total of $206M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $80 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Debt – Conventional — $80.0M
- First Round First Round
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Debt – Conventional - Unity Biotechnology | Valuation |
investors |
|
| Mar, 2018 | Amount | Series C - Unity Biotechnology | Valuation |
investors |
|
| Aug, 2017 | Amount | Series B - Unity Biotechnology | Valuation | Arch Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Unity Biotechnology
Unity Biotechnology has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, WuXi AppTec and Hercules Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Life-Sciences focused early and growth stage VC firm funding companies in China & the US
|
Founded Year | Domain | Location | |
|
Early stage life sciences sectors focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Unity Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Unity Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Unity Biotechnology Comparisons
Competitors of Unity Biotechnology
Unity Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Spark Therapeutics, Denali Therapeutics, Poseida Therapeutics, Juno Therapeutics and AskBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Unity Biotechnology
Frequently Asked Questions about Unity Biotechnology
When was Unity Biotechnology founded?
Unity Biotechnology was founded in 2016.
Where is Unity Biotechnology located?
Unity Biotechnology is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Unity Biotechnology a funded company?
Unity Biotechnology is a funded company, having raised a total of $206M across 5 funding rounds to date. The company's 1st funding round was a Series B of $35M, raised on Feb 03, 2016.
How many employees does Unity Biotechnology have?
As of Dec 31, 2024, the latest employee count at Unity Biotechnology is 16.
What does Unity Biotechnology do?
Unity Biotechnology was founded in 2016 and is headquartered in San Francisco, United States. Operations center on the biotechnology sector, where therapeutics are designed to address diseases of aging. Senolytic medicines are developed to selectively eliminate senescent cells, which are implicated in conditions such as osteoarthritis, atherosclerosis, eye diseases, and kidney diseases. A biomarker, p16(Ink4a), is utilized to create targeted approaches like the INK-ATTAC transgene for inducible cell clearance.
Who are the top competitors of Unity Biotechnology?
Unity Biotechnology's top competitors include Spark Therapeutics, Juno Therapeutics and Generation Bio.
What products or services does Unity Biotechnology offer?
Unity Biotechnology offers UBX1325.
Is Unity Biotechnology publicly traded?
Yes, Unity Biotechnology is publicly traded on OTC under the ticker symbol UNBX.
Who are Unity Biotechnology's investors?
Unity Biotechnology has 18 investors. Key investors include Fidelity Investments, WuXi AppTec, Hercules Capital, Baillie Gifford, and Arch Venture Partners.
What is Unity Biotechnology's ticker symbol?
The ticker symbol of Unity Biotechnology is UNBX on OTC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.